Inventor
HALLAKOU-BOZEC SOPHIE
FR16 patents
⚠️ This page may combine multiple inventors who share the name “HALLAKOU-BOZEC SOPHIE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CRAVO DANIEL
6 patentsUS9035048B2May 19, 2015
Tetrahydrotriazine compounds for treating diseases associated with AMPK activity
CRAVO DANIEL6 citations82
US8674097B2Mar 18, 2014
Quinoxalinedione derivatives useful as activators of AMPK-activated protein kinase
CRAVO DANIEL11 citations82
US8329698B2Dec 11, 2012
Quinoxalinedione derivatives which are activators of AMPK-activated protein kinase
CRAVO DANIEL12 citations82
US8604202B2Dec 10, 2013
Thienopyridone derivatives as AMP-activated protein kinase (AMPK) activators
CRAVO DANIEL2 citations61
US8563729B2Oct 22, 2013
Thienopyridone derivatives as AMP-activated protein kinase (AMPK) activators
CRAVO DANIEL2 citations61
US9365584B2Jun 14, 2016
Thieno [2,3-B] pyridinedione activators of AMPK and therapeutic uses thereof
CRAVO DANIEL1 citations48
POXEL
4 patentsUS9284329B2Mar 15, 2016
Thienopyridone derivatives useful as activators of AMPK
POXEL4 citations68
US12310949B2May 27, 2025
Use of a thienopyridone derivative in the treatment of autosomal dominant polycystic kidney disease (ADPKD)
POXEL0 citations57
US11850238B2Dec 26, 2023
Use of a thienopyridone derivative in the treatment of adrenoleukodystrophy or adrenomyeloneuropathy
POXEL0 citations57
US12319700B2Jun 3, 2025
Monohydrate potassium salt of a thienopyridone derivative and its preparation process
POXEL0 citations53